Literature DB >> 19713698

Impact of hyperlipidemia and statins on ischemic stroke outcomes after intra-arterial fibrinolysis and percutaneous mechanical embolectomy.

Lucas Restrepo1, Oh Young Bang, Bruce Ovbiagele, Latisha Ali, Doojin Kim, David S Liebeskind, Sidney Starkman, Fernando Vinuela, Gary R Duckwiler, Reza Jahan, Jeffrey L Saver.   

Abstract

BACKGROUND: Endovascular recanalization therapies are an increasingly employed treatment strategy in acute cerebral ischemia. The determinants of the final clinical outcome after endovascular treatment have been understudied. We investigated the effects of hyperlipidemia and statins on acute ischemic stroke outcomes after endovascular procedures.
METHODS: An inquiry of a prospectively maintained stroke registry was conducted. Endovascular procedures were performed using recombinant tissue plasminogen activator, prourokinase or the Merci device within 12 hours after symptom onset. The analyzed outcomes were revascularization, hemorrhage and excellent functional outcome (Rankin score of 0-1 at 3 months). The analyses included chi(2) and Wilcoxon rank sum, logistic regression (for multivariate analyses with binary outcomes) and linear regression (for continuous outcomes). Significance was set at p < 0.05.
RESULTS: We included 142 patients, 80% treated with intra-arterial fibrinolysis, 22% with percutaneous mechanical embolectomy and 27% treated with intravenous fibrinolysis prior to endovascular intervention. Age (OR = 0.956, 95% CI = 0.927-0.986, p = 0.0041), National Institutes of Health Stroke Scale (NIHSS) score on admission (OR = 0.881, 95% CI = 0.812-0.957, p = 0.0025) and history of hyperlipidemia (OR = 0.284, 95% CI = 0.08-0.99, p = 0.0478) were negatively associated with excellent functional outcome at 3 months. Every 50 mg/dl increment in the total cholesterol level resulted in 64% decrease in the odds of excellent functional outcome (OR = 0.36, 95% CI = 0.447-0.882, p = 0.0253). History of hyperlipidemia decreased the likelihood of neurological improvement (p = 0.0462) and was associated with a higher NIHSS score at 7 days or discharge. Statin use was related to an average 6.5-unit NIHSS decrease at discharge (p = 0.0168). Statins were not associated with increased frequency of recanalization or symptomatic intracerebral hemorrhage.
CONCLUSIONS: History of hyperlipidemia may have a negative impact on the outcomes of acute ischemic stroke treated with intra-arterial fibrinolysis or percutaneous mechanical embolectomy. Statin use before and after these procedures may be related to better neurological outcomes. Larger prospective studies are needed to endorse these findings. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19713698      PMCID: PMC2909704          DOI: 10.1159/000235625

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  29 in total

1.  Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

Authors:  G G Schwartz; A G Olsson; M D Ezekowitz; P Ganz; M F Oliver; D Waters; A Zeiher; B R Chaitman; S Leslie; T Stern
Journal:  JAMA       Date:  2001-04-04       Impact factor: 56.272

2.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

3.  Better outcome after stroke with higher serum cholesterol levels.

Authors:  C Vauthey; G R de Freitas; G van Melle; G Devuyst; J Bogousslavsky
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

4.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

5.  Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.

Authors:  S J Robins; D Collins; J T Wittes; V Papademetriou; P C Deedwania; E J Schaefer; J R McNamara; M L Kashyap; J M Hershman; L F Wexler; H B Rubins
Journal:  JAMA       Date:  2001-03-28       Impact factor: 56.272

6.  Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke.

Authors:  I Christou; A V Alexandrov; W S Burgin; A W Wojner; R A Felberg; M Malkoff; J C Grotta
Journal:  Stroke       Date:  2000-08       Impact factor: 7.914

7.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

8.  Favorable outcome of ischemic stroke in patients pretreated with statins.

Authors:  Joan Martí-Fàbregas; Meritxell Gomis; Adrià Arboix; Aitziber Aleu; Javier Pagonabarraga; Robert Belvís; Dolores Cocho; Jaume Roquer; Ana Rodríguez; María Dolores García; Laura Molina-Porcel; Jordi Díaz-Manera; Josep-Lluis Martí-Vilalta
Journal:  Stroke       Date:  2004-04-08       Impact factor: 7.914

9.  Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke.

Authors:  Jieli Chen; Zheng Gang Zhang; Yi Li; Ying Wang; Lei Wang; Hao Jiang; Chenling Zhang; Mei Lu; Mark Katakowski; Carolyn S Feldkamp; Michael Chopp
Journal:  Ann Neurol       Date:  2003-06       Impact factor: 10.422

10.  Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.

Authors:  Rory Collins; Jane Armitage; Sarah Parish; Peter Sleight; Richard Peto
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

View more
  12 in total

1.  Statin, cholesterol, and sICH after acute ischemic stroke: systematic review and meta-analysis.

Authors:  Changhong Tan; Xi Liu; Lijuan Mo; Xin Wei; Wuxue Peng; Hui Wang; Wen Zhou; Jin Jiang; Yangmei Chen; Lifen Chen
Journal:  Neurol Sci       Date:  2019-07-02       Impact factor: 3.307

2.  Quality of life after intra-arterial therapy for acute ischemic stroke.

Authors:  Melissa M Cortez; Michael J Wilder; Molly McFadden; Jennifer J Majersik
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-05-09       Impact factor: 2.136

3.  The THRombolysis and STatins (THRaST) study.

Authors:  Manuel Cappellari; Paolo Bovi; Giuseppe Moretto; Andrea Zini; Patrizia Nencini; Maria Sessa; Mauro Furlan; Alessandro Pezzini; Giovanni Orlandi; Maurizio Paciaroni; Tiziana Tassinari; Gaetano Procaccianti; Vincenzo Di Lazzaro; Luigi Bettoni; Carlo Gandolfo; Giorgio Silvestrelli; Maurizia Rasura; Giuseppe Martini; Maurizio Melis; Maria Vittoria Calloni; Fabio Chiodo-Grandi; Simone Beretta; Maria Guarino; Maria Concetta Altavista; Simona Marcheselli; Giampiero Galletti; Laura Adobbati; Massimo Del Sette; Armando Mancini; Daniele Orrico; Serena Monaco; Anna Cavallini; Rossella Sciolla; Francesco Federico; Umberto Scoditti; Fabio Brusaferri; Claudio Grassa; Luigi Specchio; Maria Roberta Bongioanni; Marco Sparaco; Mauro Zampolini; Gabriele Greco; Rinaldo Colombo; Bruno Passarella; Alessandro Adami; Domenico Consoli; Danilo Toni
Journal:  Neurology       Date:  2013-01-23       Impact factor: 9.910

Review 4.  Statins in Acute Ischemic Stroke: A Systematic Review.

Authors:  Keun-Sik Hong; Ji Sung Lee
Journal:  J Stroke       Date:  2015-09-30       Impact factor: 6.967

5.  Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.

Authors:  Cheung-Ter Ong; Yi-Sin Wong; Chi-Shun Wu; Yu-Hsiang Su
Journal:  Drug Des Devel Ther       Date:  2017-05-18       Impact factor: 4.162

6.  Early Statins after Intravenous or Endovascular Recanalization Is Beneficial Regardless of Timing, Intensity, and Stroke Mechanism.

Authors:  Han-Gil Jeong; Beom Joon Kim; Mi Hwa Yang; Moon-Ku Han; Hee-Joon Bae
Journal:  J Stroke       Date:  2017-09-29       Impact factor: 6.967

Review 7.  Clinical Variables and Genetic Risk Factors Associated with the Acute Outcome of Ischemic Stroke: A Systematic Review.

Authors:  Nuria P Torres-Aguila; Caty Carrera; Elena Muiño; Natalia Cullell; Jara Cárcel-Márquez; Cristina Gallego-Fabrega; Jonathan González-Sánchez; Alejandro Bustamante; Pilar Delgado; Laura Ibañez; Laura Heitsch; Jerzy Krupinski; Joan Montaner; Joan Martí-Fàbregas; Carlos Cruchaga; Jin-Moo Lee; Israel Fernandez-Cadenas
Journal:  J Stroke       Date:  2019-09-30       Impact factor: 6.967

8.  Influence of lipid profiles on the risk of hemorrhagic transformation after ischemic stroke: systematic review.

Authors:  Katiuscia Nardi; Didier Leys; Paolo Eusebi; Charlotte Cordonnier; Sophie Gautier; Hilde Hénon; Régis Bordet
Journal:  Cerebrovasc Dis Extra       Date:  2011-12-29

9.  Mechanically assisted intra-arterial thrombolysis in acute cerebral infarction.

Authors:  Hui-Xiao Wang; Yi-Jin Shen; Shu-Jun Ye; Yong-Kang Xu; Jian-Pin Zhang; Zhou Lu
Journal:  Exp Ther Med       Date:  2013-03-06       Impact factor: 2.447

10.  Hyperlipidemia in Stroke Pathobiology and Therapy: Insights and Perspectives.

Authors:  Romain Menet; Maxime Bernard; Ayman ElAli
Journal:  Front Physiol       Date:  2018-05-15       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.